Novavax (NVAX) Misses Q4 EPS, Revenues; Provides Vaccine Updates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 10.08 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.08 | 52 Week High | $9.23 | |||
| Open | $10.08 | 52 Week Low | $1.16 | |||
| Day High | $10.08 | P/E | N/A | |||
| Day Low | $10.08 | EPS | $-0.30 | |||
| Volume | 7,586 | |||||
